Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. (Q55463299)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. (English)

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

DNA mismatch repair

1 reference

based on heuristic

inferred from title

11

object named as

Michael Weller

1 reference

Europe PubMed Central

12 July 2018

Guido Reifenberger

12

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

12 July 2018

1

object named as

Jörg Felsberg

1 reference

Europe PubMed Central

12 July 2018

Jörg-Christian Tonn

13

object named as

Jörg C Tonn

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

author name string

Niklas Thon

2

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Sabina Eigenbrod

3

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Bettina Hentschel

4

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Michael C Sabel

5

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Manfred Westphal

6

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Gabriele Schackert

7

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Friedrich Wilhelm Kreth

8

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Torsten Pietsch

9

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Markus Löffler

10

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

German Glioma Network

14

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

language of work or name

0 references

publication date

1 August 2011

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

International Journal of Cancer

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

129

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

3

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

659-670

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Mechanisms of chemoresistance to alkylating agents in malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Microsatellite instability and mutation of DNA mismatch repair genes in gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Microsatellite instability and the PTEN1 gene mutation in a subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1 gene.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Promoter hypermethylation of mismatch repair gene hMLH1 predicts the clinical response of malignant astrocytomas to nitrosourea

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Epigenetic inactivation of the hMLH1 gene in progression of gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26083

21 January 2018

Identifiers

10.1002/IJC.26083

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/21425258

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55463299&oldid=1872314924"